ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONVO Organovo Holdings Inc

1.12
0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.12 19:00:00
Open Price Low Price High Price Close Price Prev Close
1.10 1.09 1.29 1.15 1.12
more quote information »

Recent News

Date Time Source Heading
4/15/202408:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
2/09/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/08/202416:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202416:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202408:05EDGAR2Form 8-K - Current report
1/26/202417:09EDGAR2Form S-3 - Registration statement under Securities Act of..
1/25/202408:05GLOBEOrganovo Presents FXR314 3D Human Tissue Model Findings That..
1/09/202408:05GLOBEOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming..
12/28/202316:05EDGAR2Form 8-K - Current report
12/22/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202308:05GLOBEOrganovo Provides Timing for Release of FXR314 Phase 2 NASH..
12/01/202316:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/17/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202316:41EDGAR2Form 144 - Report of proposed sale of securities
11/13/202308:05GLOBECORRECTION – Organovo Highlights FXR314 Combination Therapy..
11/09/202317:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202308:05GLOBEOrganovo Highlights FXR314 Combination Therapy Potential and..
11/03/202308:05EDGAR2Form 8-K - Current report
9/22/202316:05EDGAR2Form 8-K/A - Current report: [Amend]
9/13/202317:06EDGAR2Form DEF 14A - Other definitive proxy statements
9/13/202317:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/12/202316:11EDGAR2Form 8-K - Current report
9/08/202312:46GLOBEOrganovo to Participate in the H.C. Wainwright Global..
9/05/202306:04EDGAR2Form 8-K - Current report
8/23/202308:05GLOBEOrganovo Advances Clinical Timelines for FXR314 and Provides..
8/22/202316:45EDGAR2Form 8-K - Current report
8/10/202316:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202316:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
7/24/202316:27EDGAR2Form 8-K - Current report
7/14/202317:05EDGAR2Form PRE 14A - Other preliminary proxy statements
6/29/202316:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..

Your Recent History

Delayed Upgrade Clock